Efficacy and Safety of Limertinib (ASK120067) in Patients With Locally Advanced or Metastatic EGFR Thr790Met-Mutated NSCLC: A Multicenter, Single-Arm, Phase 2b Study
Yuankai Shi(Chinese Academy of Medical Sciences & Peking Union Medical College), Tingting Song(Xinjiang Medical University), Helong Zhang(Shanghai International Studies University), Qiming Wang(Henan Cancer Hospital), Li Zeng(Convalife (China)), Xinri Zhang(Shanxi Medical University), Lin Wang(Monash University), Yanping Hu(Chinese People's Liberation Army), Tong Zhou(Xiamen University), Qinglian Wen(Southwest Medical University), Daqing Wang(Harrison International Peace Hospital), Aimin Zang, Hongjun Gao(Chinese PLA General Hospital), Lin Wu(Materials Systems (United States)), Gongyan Chen, Jian Fang(Peking University), Zonghui Wei, Guo‐Jun Zhang(Kunming Medical University), Yi Zhang(Tianjin Medical University General Hospital), Xiang Wang(Central South University), Yu Zhang(Fujian Medical University), Hailong Liu(Capital Medical University), Qin Shi(Soochow University), Zhiyong He(Albert Einstein College of Medicine), Yun Fan(Zhejiang Cancer Hospital), Hongda Lu(Huazhong University of Science and Technology), Kangsheng Gu(Anhui Medical University), Rui Ma(Air Force Medical University), Jianhua Shi(Linyi People's Hospital), Xiuwen Wang(Second Hospital of Shandong University), Runxiang Yang(Kunming Medical University), Baolan Li(Capital Medical University), Yinghua Ji(First Affiliated Hospital of Xinxiang Medical University), Zhijie Pan(Chinese PLA General Hospital), Yuansong Bai(First Bethune Hospital of Jilin University), Yunpeng Liu(Shenyang Institute of Automation), Linian Huang(First Affiliated Hospital of Bengbu Medical College), Jianbing Hu(Shanghai University of Traditional Chinese Medicine), Yueyin Pan(University of Science and Technology of China), Hongyu Chen(Wrocław University of Environmental and Life Sciences), Da Jiang(Hebei Medical University)
Cited by 29
Related Papers
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study
|The Lancet|2020|29.1k
A Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe Covid-19
|New England Journal of Medicine|2020|5.5k
The Role of Tumoral FOXP3 on Cell Proliferation, Migration, and Invasion in Gastric Cancer
|Cellular Physiology and Biochemistry|2017|4.1k